Biofern Life Sciences Private Limited, a active private limited company, was established on 11 January 2019 in Bengaluru, Karnataka, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24100KA2019PTC120330. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹27.00 Cr and a paid-up capital of ₹27.00 Cr.
It upholds a compliant status. Its leadership includes Kolathur Srinarayanan (Director), Burugupalli Srinivas (Director), Garikipati Kishore Kumar (Director). Past directors included M.H. Shyama Prasad, M.H. Shyama Prasad. It holds ₹13.85 Cr open charges and ₹13.00 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No. 706, Ground Floor, 3 A Cross, 1St Block, Hrbr Layout, Kalyan Nagar,, Bengaluru, Karnataka, 560043.
U24100KA2019PTC120330
120330
11 January 2019
₹27.00 Cr
₹27.00 Cr
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Biofern Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kolathur Srinarayanan | Director | 11 Jan 2019 | Current |
| Burugupalli Srinivas | Director | 11 Jan 2019 | Current |
| Garikipati Kishore Kumar | Director | 11 Jan 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Biofern Life Sciences Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 100.07% increase in profit. The company's net worth Soared by an impressive increase of 108%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
In 2023, Biofern Life Sciences had a promoter holding of 39.33% and a public holding of 60.67%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹138,500,000.00
₹130,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Nov 2023 | Axis Bank Limited | ₹13.85 Cr | Open |
| 24 Jul 2023 | Karnataka Bank Ltd. | ₹2.00 Cr | Satisfied |
| 18 Apr 2023 | Karnataka Bank Ltd. | ₹3.00 Cr | Satisfied |
| 16 Jun 2022 | Karnataka Bank Ltd. | ₹8.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Biofern Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Biofern Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biofern Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Axis Bank Limited of Rs. 13.85 Cr registered on 17 Nov 2023 with Charge ID 100828149 was modified on 02 Aug 2025. was recorded as a recent event.
Biofern Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
A charge registered on 24 Jul 2023 via Charge ID 100764930 with Karnataka Bank Ltd. was fully satisfied on 19 Apr 2024. was recorded as a recent event.
The activity A charge registered on 18 Apr 2023 via Charge ID 100716099 with Karnataka Bank Ltd. was fully satisfied on 19 Apr 2024. was completed.
The activity A charge registered on 16 Jun 2022 via Charge ID 100589838 with Karnataka Bank Ltd. was fully satisfied on 18 Apr 2024. was completed.
Progress on Biofern Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was documented.
The CIN of Biofern Life Sciences Private Limited is U24100KA2019PTC120330.
Biofern Life Sciences Private Limited is headquartered at No. 706, Ground Floor, 3 A Cross, 1St Block, Hrbr Layout, Kalyan Nagar,, Bengaluru, Karnataka, 560043.
Biofern Life Sciences Private Limited was incorporated on 11 January 2019.
The current directors of Biofern Life Sciences Private Limited are
The primary industry of Biofern Life Sciences Private Limited is Pharma.
Biofern Life Sciences Private Limited is unlisted.
The authorized capital of Biofern Life Sciences Private Limited is ₹27.00 Cr, and the paid-up capital is ₹27.00 Cr.
The compliance status of Biofern Life Sciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX